BDBM504254 (R)-N-(6-(4-((3-Ethylisoxazol-4- yl)methyl)piperazin-1-yl)-2-(2- fluoro-3-hydroxy-3- methylbutyl)-1-oxoisoindolin-5- yl)pyrazolo[1,5-a]pyrimidine-3- carboxamide::US11034698, Example 104

SMILES CCc1nocc1CN1CCN(CC1)c1cc2C(=O)N(C[C@@H](F)C(C)(C)O)Cc2cc1NC(=O)c1cnn2cccnc12

InChI Key InChIKey=YIBYLDODPYYHFV-UHFFFAOYSA-N

Data  1 KI

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 504254   

TargetNuclear receptor ROR-gamma(Human)
Genentech

US Patent
LigandPNGBDBM504254((R)-N-(6-(4-((3-Ethylisoxazol-4- yl)methyl)piperaz...)
Affinity DataKi:  5nMAssay Description:The IRAK4 reaction conditions were optimized using an IRAK1-derived peptide (sequence H-KKARFSRFAGSSPSQSSMVAR) to provide a linear reaction rate over...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/5/2021
Entry Details
US Patent